Hi all - FYI my registration for this briefing has been confirmed, though it took a couple of days over the long weekend. For interest, here are my draft questions:
1. Has the Elanco Phase II Dog Dossier been submitted and what are the next milestones for an agreement?
2. When will the MPL Phase II Human Cancer trial design be communicated and when will it start?
3. What are the next steps for MPL SARS-CoVID trials and how well does this fit with PAA Strategy?
4. Is the Epichem customer contract pipeline growing and profitable in these challenging times?
If there are better questions that I can ask let me know.
Regards
- Forums
- ASX - By Stock
- NUZ
- Ann: Virtual Investor Briefing
Ann: Virtual Investor Briefing, page-29
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $111.9M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 22.0¢ | $138.6K | 602.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11933 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 149886 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 360640 | 0.220 |
8 | 709501 | 0.215 |
4 | 104821 | 0.210 |
2 | 98485 | 0.205 |
4 | 119988 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 149886 | 4 |
0.240 | 282926 | 4 |
0.245 | 364236 | 5 |
0.250 | 391054 | 7 |
0.260 | 180162 | 3 |
Last trade - 12.49pm 16/10/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online